National Science Foundation

Auxilium Health is creating low-cost, smart biomaterials for difficult-to-heal wounds.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

LiteraSeed operates a clinically validated digital health platform designed to enhance communication between healthcare providers and low health literate patient populations. The platform addresses significant challenges faced by public health providers, particularly in serving patients who may not speak English or have other communication barriers. By enabling these individuals to accurately and remotely self-report symptoms, LiteraSeed aims to prevent costly misdiagnoses, adverse events, and unnecessary emergency room admissions. This approach not only improves access to care for disadvantaged patients but also makes clinical encounters more productive, fostering better understanding of health status and overall patient outcomes.

CenSyn is a brain health screening platform focused on enhancing the accessibility and efficiency of diagnosing various neurological conditions. The company has developed a handheld EEG monitoring device aimed at accelerating the screening process for Alzheimer's, traumatic brain injury, and epilepsy. Their proprietary software facilitates long-term management of brain health by allowing clinicians to wirelessly monitor and record brain electrical activity in real time. This innovative approach enables the rapid detection of altered mental status, supporting timely diagnosis and immediate treatment, ultimately reducing inpatient costs and improving care for diverse patient populations.

Alerje, Inc. is a company based in Detroit, Michigan, specializing in emergency medicine and digital oral immunotherapy management for individuals with food allergies. Founded in 2015, Alerje has developed an innovative epinephrine auto-injector designed to fit within a smartphone case, enhancing patient adherence and emergency response capabilities. The accompanying mobile application allows users to create personalized food allergy profiles, share this information with their CareCircle—comprising family, friends, caregivers, and medical professionals—and receive location alerts. Additionally, the platform enables users to filter recipes and scan grocery items for potential allergens, thereby improving dietary decision-making. Alerje's system has been validated by the National Science Foundation, emphasizing its commitment to enhancing the quality of life for those affected by food allergies.

Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

ProMedix is a medical device startup founded in 2019 and headquartered in Portland, Oregon. The company specializes in developing noninvasive, fingertip patient monitors aimed at enhancing the recognition of circulatory dysfunction. Its innovative devices facilitate diagnostic evaluations and the monitoring of therapeutic interventions for various medical conditions, such as trauma, dehydration, and sepsis. By improving home patient monitoring, ProMedix enables physicians to streamline care in both home and critical settings, thereby preventing unnecessary acute visits and enhancing emergency or critical care outcomes.

Claria Medical is a pre-commercial medical device start-up focused on developing innovative solutions for women's healthcare, specifically targeting unmet needs in gynecologic surgery. The company specializes in creating minimally invasive surgical tools designed to enhance procedures such as hysterectomy and myomectomy. Claria Medical has received recognition for its early achievements, including a “Safer Technologies Designation” from the U.S. Food and Drug Administration. Additionally, the company has secured funding through private investments as well as grants from the National Science Foundation and the National Institutes of Health to support its product development efforts. By providing specialized surgical assistance, Claria Medical aims to improve outcomes for women undergoing these procedures.

Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

Phaxtec specializes in developing and supplying eco-friendly material solutions, primarily focusing on the foodservice packaging, agriculture, and personal care sectors. The company's key product is polyhydroxyalkanoate (PHA) biopolymers, which are not only recyclable but also biodegradable in various environments, including soil, freshwater, and marine settings. This makes Phaxtec's offerings an attractive alternative for businesses seeking to reduce their environmental impact and transition towards more sustainable practices.

HairDays is an AI-powered health data company that has developed a unique hair intelligence platform focused on simplifying hair classification and care. The platform provides tailored recommendations for maintaining healthy hair, allowing consumers to discover and purchase hair care products suited to their individual needs. By curating relevant content, HairDays enables users to monitor their hair conditions and track their growth progress effectively. This innovative approach eliminates the guesswork often associated with hair care, empowering individuals to make informed decisions about their hair health.

Lura Health has developed a groundbreaking non-invasive health monitoring platform that utilizes saliva as a diagnostic fluid, aiming to enhance clinical outcomes in chronic disease management. Founded in 2017 and based in Cambridge, Massachusetts, the company targets various chronic disease markets, including heart disease, chronic kidney disease, diabetes, and tooth decay. Its innovative sensors are integrated into patient-friendly orthodontic devices such as removable retainers and fixed braces. These sensors continuously measure analytes in saliva and automatically transmit data to a smartphone application, allowing users to track key diagnostic metrics related to their oral health. By enabling individuals to monitor their health in real-time, Lura Health seeks to improve personal health management and empower users to take charge of their well-being.

UCHU Biosensors develops a platform of tooth mounted sensors to effortlessly track health through saliva.

Our mission is to promote innovation that empowers people to have the knowledge and tools to solve everyday medical problems in any setting. We do this by providing a doctor’s approach to stopping nosebleeds at your fingertips. Bleed Freeze allows people to confidently take control and treat nosebleeds anywhere.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Liv Labs is a consumer health technology company focused on enhancing pelvic floor fitness for women globally. The company offers an affordable pelvic floor fitness kit designed to help manage urinary leakage during various physical activities. By providing convenient solutions, Liv Labs aims to empower women to control urinary leaks and restore natural continence, promoting overall health and well-being.

Quadralynx specializes in the development of wearable biometric devices tailored for adults experiencing motor speech disorders, particularly those who face challenges with volume control due to Parkinson's disease and similar neurological conditions. The company's innovative device employs biofeedback technology to alert users through vibrations when their voice reaches a pathological state. By focusing on speech and voice improvement, Quadralynx aims to enhance the quality of life for individuals affected by these disorders.

Echowear is a company focused on enhancing healthcare access through an innovative smartwatch-based system. This system is designed to facilitate meaningful interactions between patients and care teams, ultimately creating actionable digital health services. Echowear's approach aims to provide users with age-friendly health technologies, allowing for a more inclusive and effective healthcare experience. By leveraging digital solutions, the company seeks to improve patient engagement and streamline communication within the healthcare ecosystem.

Pragma Health provides digital healthcare services. They permit users to perform different tests for cardiovascular, hematology, infectious diseases, and others in the privacy of their home and provide accurate, immediate results, enabling them to get a convenient, cost-effective, and accurate healthcare testing process.

Empo Health specializes in in-home health monitoring solutions that enhance patient care by integrating seamlessly into daily life. The company has developed an innovative imaging bathroom scale and a digital health platform aimed at detecting early signs of diabetic foot conditions, thereby helping to prevent amputations. By providing reliable visual data outside of clinical settings, Empo Health enables both patients and clinicians to monitor health effectively and maintain standards of care. Through its advanced technology, the company seeks to improve health outcomes and foster proactive management of chronic conditions.

Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

Innsightful offers a comprehensive digital health solution aimed at managing and alleviating mental health challenges, particularly for students. The company develops wearable devices that monitor and detect symptoms of anxiety and stress, utilizing artificial intelligence and machine learning to provide automated, early detection of heightened stress levels. These devices integrate biometrics to give users personalized insights, fostering a deeper understanding of their mental health. Additionally, Innsightful facilitates access to therapists for tailored recommendations and progress assessments, transforming how individuals approach their mental well-being.

LiteraSeed operates a clinically validated digital health platform designed to enhance communication between healthcare providers and low health literate patient populations. The platform addresses significant challenges faced by public health providers, particularly in serving patients who may not speak English or have other communication barriers. By enabling these individuals to accurately and remotely self-report symptoms, LiteraSeed aims to prevent costly misdiagnoses, adverse events, and unnecessary emergency room admissions. This approach not only improves access to care for disadvantaged patients but also makes clinical encounters more productive, fostering better understanding of health status and overall patient outcomes.

Alerje, Inc. is a company based in Detroit, Michigan, specializing in emergency medicine and digital oral immunotherapy management for individuals with food allergies. Founded in 2015, Alerje has developed an innovative epinephrine auto-injector designed to fit within a smartphone case, enhancing patient adherence and emergency response capabilities. The accompanying mobile application allows users to create personalized food allergy profiles, share this information with their CareCircle—comprising family, friends, caregivers, and medical professionals—and receive location alerts. Additionally, the platform enables users to filter recipes and scan grocery items for potential allergens, thereby improving dietary decision-making. Alerje's system has been validated by the National Science Foundation, emphasizing its commitment to enhancing the quality of life for those affected by food allergies.

Notus Labs specializes in developing wearable devices that enable individuals to monitor their health and performance in a remote and non-invasive manner. These devices provide a continuous and comprehensive summary of vital signs, which can help optimize medical triaging during instances of sudden physiological deterioration. By utilizing Notus Labs' technology, users can effectively mitigate the risks associated with overexertion injuries and heat-related illnesses. Additionally, the devices offer training suggestions to enhance physical performance, allowing users to maximize their growth while maintaining safety during physical activities.

Midday is an app that leverages AI, sensor technology, and digital therapeutics to support women on their menopause journey using personalized insights that illuminate what is happening physically and emotionally during menopause, providing the right intervention at the right time to manage menopause symptoms and promote healthy aging.

Alva Health specializes in the development of healthcare wearables focused on remote stroke monitoring. The company's patented devices operate continuously to detect stroke signatures, specifically identifying the onset of hemiparesis, or paralysis on one side of the body. By connecting users to emergency services, Alva Health's technology aims to empower older adults at high risk of stroke, facilitating early intervention to prevent disability. The company is committed to transforming stroke treatment and advancing neurotechnologies that enhance patient safety and independence, ultimately providing peace of mind for families.

Immersive Reality Group, founded in 2004 and based in Bozeman, Montana, specializes in using artificial intelligence and virtual reality technology to deliver personalized healthcare solutions focused on mental health. The company operates a platform designed for stress and anxiety management, which integrates predictive analytics for health monitoring in a home setting. Through its innovative virtual reality experiences, Immersive Reality Group aims to provide users with real-time relief from stress and anxiety symptoms while also offering tools to develop effective coping strategies.

SweatID is a developer of wearable fabric sensors designed for health and fitness applications. Their sensors help to monitor hydration on the surface of the skin in real time, enabling users to continuously monitor biomarkers.

Quick-Med Technologies, Inc. is a life sciences company dedicated to developing proprietary technologies aimed at infection prevention and control in both medical and consumer healthcare markets. Founded in 1997 and headquartered in Gainesville, Florida, the company specializes in biomedical products and devices with antibacterial applications. Its core technologies include Novel Intrinsically Micro-Bonded Utility Substrate (NIMBUS), a series of advanced polymers with antimicrobial and hemostatic properties; Stay Fresh, a chemical formulation for textiles that provides durable antimicrobial protection; and MultiStat, which comprises patented methods and compounds for skin therapy. Quick-Med serves a diverse range of clients, including government agencies, healthcare providers, and companies in the apparel, textile, and personal care sectors.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Active Therapy Systems is a company based in Nicholasville, Kentucky, founded in 2017. It specializes in developing an interactive exercise platform designed to provide in-home therapies for individuals living with Parkinson's disease. The platform aims to enhance the management of Parkinson's through personalized therapies and remote patient monitoring, allowing users to engage in activities that may help alleviate their symptoms. By focusing on the specific needs of those affected by Parkinson's, Active Therapy Systems seeks to improve their quality of life and promote greater independence in daily activities.

Kepler Diagnostics is a healthcare technology company focused on enhancing research and health outcomes through innovative specimen collection devices. The company provides solutions that stabilize sensitive tests and enable remote collection of various bodily fluids, including urine, serum, and plasma. These devices facilitate simple transportation at ambient temperature, making it easier for individuals to access accurate and cost-effective diagnostic services within their communities. By improving the specimen collection process, Kepler Diagnostics aims to contribute to better health and wellness for users.

Proov is a company that specializes in developing rapid response urine test strips for measuring progesterone, a hormone essential for confirming ovulation and supporting conception. Unlike traditional in-home tests that primarily measure hormones like LH, FSH, and estrogen during the early menstrual cycle, Proov's tests provide a more comprehensive assessment by specifically tracking progesterone levels. This capability allows women to not only predict ovulation but also to identify potential hormonal imbalances that may contribute to infertility or miscarriage. By enabling women to monitor their hormonal health at home, Proov offers a cost-effective alternative to fertility clinics and IVF treatments, empowering them to take control of their reproductive health.

Fathhome is a company based in Oakland, California, that specializes in the development of a sanitizing device designed for the dry sanitization of various household items. Founded in 2015, Fathhome's innovative device employs air pressure and ionization technology to effectively sanitize items such as packages, clothes, shoes, helmets, personal protective equipment, and electronic devices like phones and computers. This approach allows users to eliminate harmful viruses and bacteria without the need for water, detergents, or chemicals, providing a convenient and effective solution for maintaining cleanliness in everyday life.

Progenitor MDX is engaged in developing cellular immunotherapy technologies that facilitate the creation of induced pluripotent stem cells for use in immune-oncology and engineered cell therapies. The company combines all Yamanaka factors into a single vector, enabling simple and reliable cellular reprogramming. This innovation supports the efficient production of allogeneic off-the-shelf CAR constructs derived from various cell sources. In addition to its focus on cellular immunotherapy, Progenitor MDX offers a comprehensive and customizable solution for managing COVID-19 infections, which includes providing testing results and actionable plans for infection management to support community health.

BiomeSense, Inc. is a company that specializes in developing an integrated platform combining hardware, software, and data analytics to enhance the collection and analysis of microbiome data in clinical research. Founded in 2018 and based in Chicago, Illinois, BiomeSense has created the GutLab, an innovative "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology, along with the MetaBiome time-series analytics platform, provides a comprehensive solution that enables researchers, patients, and consumers to track microbiome changes in real time and understand their impact on health outcomes. By generating and analyzing large-scale, longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, ultimately improving precision medicine and the development of microbiome-based therapeutics and products.

Lasarrus is a Baltimore-based company founded in 2013 that specializes in developing wearable devices for patients with chronic obstructive pulmonary disease (COPD). The company's innovative device is designed to enhance physical therapy by facilitating telemedicine and remote monitoring. It captures physiological and range-of-motion data, allowing patients to track their health routines effectively. Lasarrus aims to provide an affordable, comfortable, and non-invasive solution that accelerates recovery for users, improving their overall health management.

Claria Medical is a pre-commercial medical device start-up focused on developing innovative solutions for women's healthcare, specifically targeting unmet needs in gynecologic surgery. The company specializes in creating minimally invasive surgical tools designed to enhance procedures such as hysterectomy and myomectomy. Claria Medical has received recognition for its early achievements, including a “Safer Technologies Designation” from the U.S. Food and Drug Administration. Additionally, the company has secured funding through private investments as well as grants from the National Science Foundation and the National Institutes of Health to support its product development efforts. By providing specialized surgical assistance, Claria Medical aims to improve outcomes for women undergoing these procedures.

Starling Medical focuses on creating a remote patient monitoring platform that facilitates at-home urine diagnostics, integrating seamlessly into everyday bathroom routines. The company is developing a healthcare device that employs mass spectroscopy-based sensors to continuously monitor changes in urine composition. This technology aims to enable early detection of chronic health issues, allowing both patients and healthcare providers to intervene promptly and potentially prevent serious complications or hospitalizations. By offering predictive insights, Starling Medical aspires to enhance health outcomes through proactive monitoring.

Intake Health is a developer of a continuous passive health monitoring device that operates at home without requiring changes in user behavior. The device is designed to be mounted on a toilet, where it automatically tests urine from flush water to deliver lab-quality results for various health and dietary indicators. By leveraging advanced biosensors and wireless technology, the system accurately tracks hydration and nutrition by quantifying specific urinary biomarkers. Users receive instant insights on their health metrics through a mobile application, facilitating informed decision-making regarding their well-being. Intake Health aims to enhance health predictions and personalized prevention strategies through the accumulation of personalized biomarkers over time. The company has received funding from the National Science Foundation and the National Institutes of Health.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior develops a platform that combines wearable devices and machine learning algorithms to monitor key physiological signals such as heart rate and motion. This system, known as Recovery, is designed to support mental health recovery and wellness by delivering timely interventions based on real-time data. By utilizing a software-as-a-service (SaaS) model, Behaivior empowers individuals to maintain their recovery process while enabling care providers to better assist their clients. The integration of AI and behavioral health technology allows Behaivior to recognize patterns in human behavior, ultimately aiming to enhance mental well-being and reduce the incidence of crises, including relapse.

Lura Health has developed a groundbreaking non-invasive health monitoring platform that utilizes saliva as a diagnostic fluid, aiming to enhance clinical outcomes in chronic disease management. Founded in 2017 and based in Cambridge, Massachusetts, the company targets various chronic disease markets, including heart disease, chronic kidney disease, diabetes, and tooth decay. Its innovative sensors are integrated into patient-friendly orthodontic devices such as removable retainers and fixed braces. These sensors continuously measure analytes in saliva and automatically transmit data to a smartphone application, allowing users to track key diagnostic metrics related to their oral health. By enabling individuals to monitor their health in real-time, Lura Health seeks to improve personal health management and empower users to take charge of their well-being.

Telling.ai is a telehealth platform focused on assessing lung health through the analysis of voice and breath sounds. By capturing respiratory sounds in real-world settings, the company provides real-time feedback and optimizes data quality to support individuals with chronic lung conditions. Their technology identifies signatures in breath and speech that indicate various medical conditions, including respiratory diseases and infections. Telling.ai aims to assist in the management of care for over 1 billion people suffering from acute or chronic respiratory disorders, enabling timely interventions that can prevent costly hospitalizations and improve overall patient outcomes.

UCHU Biosensors develops a platform of tooth mounted sensors to effortlessly track health through saliva.

Rizlab Health is a medical device startup founded in 2018 and based in East Princeton. The company specializes in providing practitioners and patients with rapid blood count readings, specifically focusing on white blood cell analysis. Rizlab Health's electronic cytometer and analyzer utilize a cartridge system to quantify key cellular components, such as neutrophils and lymphocytes. This technology enables hospitals and healthcare providers to quickly and affordably monitor patients' white blood counts, which is crucial for diagnosing conditions like sepsis and distinguishing between bacterial and viral infections. By offering a fast, portable, and cost-effective health monitoring solution, Rizlab Health aims to enhance patient care and streamline clinical decision-making processes.

Koya Medical, Inc., founded in 2018 and based in Oakland, California, specializes in developing innovative therapeutic devices aimed at treating cancer-related chronic lymphedema and various venous diseases. The company focuses on creating wearable technology that delivers active compression therapy, which is designed to enhance movement and mobility for patients. Koya Medical's approach offers a personalized alternative to traditional compression methods, utilizing a sensor-based closed-loop system to provide tailored compression patterns. This technology addresses the needs of patients suffering from conditions such as lymphedema, chronic edema, and chronic venous insufficiency, thereby improving their quality of care and overall treatment outcomes.

Sumaq Life is a technology company specializing in AI-driven healthcare solutions. It focuses on identifying cancer patients eligible for genomic testing by integrating with electronic medical records. The company then employs gene regulatory modeling to develop personalized treatment plans, targeting therapy for a higher chance of success across various aggressive cancer types.

Manus Robotics is focused on developing a smart health and wellness device aimed at promoting independent and healthy living. The company offers a wearable robot that assists individuals with disabilities in their daily activities, providing intelligent support to enhance their quality of life. In addition to daily living assistance, the device collects and analyzes muscle data from patients, facilitating rehabilitation efforts and helping users regain independence.

HumanGo Training is an imagined solution that understands an athlete’s life beyond their training that knows how many last-minute, unexpected work, family, and friends things can come up in a week.

Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

BioLum Sciences LLC, founded in 2015 and based in Dallas, Texas, focuses on developing innovative asthma management devices that enable patients to monitor airway inflammation. The company specializes in bioanalytical chemistry and medical device development, utilizing a chemiluminescent platform to measure biomarkers in exhaled breath condensate and blood samples. Their primary product, the BioSense Airway Monitoring Device (AMD), allows for at-home monitoring of lung function by measuring oxidative stress biomarkers without complicated breathing maneuvers. This technology not only aids patients in tracking their symptoms and medication efficacy but also provides physicians with vital data to optimize treatment plans. Additionally, BioLum’s blood analysis product offers a simple finger-prick test to assess nitric oxide levels and cardiovascular health. The company's initiatives extend to addressing chronic diseases such as asthma, chronic obstructive pulmonary disease (COPD), hypertension, and heart failure, supporting both clinicians and researchers in personalizing treatment strategies and improving patient outcomes.

Storx Technologies specializes in developing medical devices aimed at enhancing the health and safety of mothers and infants during labor and delivery. The company's technology focuses on monitoring fetal health, providing accurate assessments of a baby's well-being in the womb. This information assists healthcare professionals in making informed decisions about the delivery method, potentially reducing the likelihood of unnecessary cesarean sections. By improving the decision-making process during childbirth, Storx Technologies contributes to better outcomes for both mothers and babies.

Iterex is dedicated to revolutionizing at-home care of chronic illnesses through early, cost effective, personalized mobile digital health applications.

Viora Health is a health and wellness company focused on advancing health equity among diverse populations. It offers tech-enabled, human-centered programs that utilize social and behavioral engagement to enhance capacity, satisfaction, outcomes, and revenue for healthcare providers. The company is backed by funding from reputable organizations such as the American Heart Association, the National Institutes of Health, Johnson and Johnson, and the National Science Foundation, with its initiatives validated through an Institutional Review Board-approved study. Viora Health's programs have demonstrated a 75% satisfaction score, double retention rates, and improved health outcomes, including reduced stress and better access to food and social support. Additionally, Viora Health develops a healthcare compliance platform aimed at enhancing adherence to diabetes prevention initiatives by connecting patients to programs, tracking data, and facilitating online engagement tools, which help diabetes prevention programs comply with insurance requirements and achieve outcome-based reimbursement.

VitalFlo Inc. is a digital health company based in Raleigh, North Carolina, established in 2017. It specializes in manufacturing handheld spirometers for asthmatic patients, allowing them to monitor their lung health and medication use. In addition to the spirometers, VitalFlo develops software that connects patients with chronic respiratory conditions to their healthcare providers. The company's remote monitoring system tracks lung function and environmental factors that may trigger asthma attacks, providing actionable insights to clinical teams. This innovative approach aims to reduce emergency room visits by offering timely recommendations to patients, thereby redefining asthma management and enhancing overall care.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Alva Health specializes in the development of healthcare wearables focused on remote stroke monitoring. The company's patented devices operate continuously to detect stroke signatures, specifically identifying the onset of hemiparesis, or paralysis on one side of the body. By connecting users to emergency services, Alva Health's technology aims to empower older adults at high risk of stroke, facilitating early intervention to prevent disability. The company is committed to transforming stroke treatment and advancing neurotechnologies that enhance patient safety and independence, ultimately providing peace of mind for families.

Lasarrus is a Baltimore-based company founded in 2013 that specializes in developing wearable devices for patients with chronic obstructive pulmonary disease (COPD). The company's innovative device is designed to enhance physical therapy by facilitating telemedicine and remote monitoring. It captures physiological and range-of-motion data, allowing patients to track their health routines effectively. Lasarrus aims to provide an affordable, comfortable, and non-invasive solution that accelerates recovery for users, improving their overall health management.

HeroWear is a company focused on developing innovative wearable technology designed to enhance worker safety, health, and productivity in physically demanding roles. Their flagship product, the Apex, is a back-assist exosuit specifically engineered for both men and women. This garment aims to alleviate back strain and fatigue while maintaining the comfort of everyday clothing. The Apex incorporates patent-pending dual-mode technology, which allows users to easily toggle back support on and off, making it versatile for various work environments. Additionally, the exosuit's modular textile design offers over 50 customizable combinations, ensuring that it can be tailored to fit the specific needs of any worker engaged in strenuous tasks. Through these advancements, HeroWear aims to reduce physical strain and improve the overall well-being of employees in demanding jobs.

Intake Health is a developer of a continuous passive health monitoring device that operates at home without requiring changes in user behavior. The device is designed to be mounted on a toilet, where it automatically tests urine from flush water to deliver lab-quality results for various health and dietary indicators. By leveraging advanced biosensors and wireless technology, the system accurately tracks hydration and nutrition by quantifying specific urinary biomarkers. Users receive instant insights on their health metrics through a mobile application, facilitating informed decision-making regarding their well-being. Intake Health aims to enhance health predictions and personalized prevention strategies through the accumulation of personalized biomarkers over time. The company has received funding from the National Science Foundation and the National Institutes of Health.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

SweatID is a developer of wearable fabric sensors designed for health and fitness applications. Their sensors help to monitor hydration on the surface of the skin in real time, enabling users to continuously monitor biomarkers.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior develops a platform that combines wearable devices and machine learning algorithms to monitor key physiological signals such as heart rate and motion. This system, known as Recovery, is designed to support mental health recovery and wellness by delivering timely interventions based on real-time data. By utilizing a software-as-a-service (SaaS) model, Behaivior empowers individuals to maintain their recovery process while enabling care providers to better assist their clients. The integration of AI and behavioral health technology allows Behaivior to recognize patterns in human behavior, ultimately aiming to enhance mental well-being and reduce the incidence of crises, including relapse.

Tanzen Medical, founded in 2017 and located in Severna Park, Maryland, specializes in the development of clinically accurate wearable devices aimed at assessing and enhancing sleep quality in a home setting. The company's innovative technology is designed to aid in the diagnosis of sleep-related disorders, such as ADHD and narcolepsy, by monitoring nightly leg movements. This functionality allows users to track various aspects of their sleep, including quality, position, and arousal, ultimately promoting better sleep health.

Iterex is dedicated to revolutionizing at-home care of chronic illnesses through early, cost effective, personalized mobile digital health applications.

Samay is a developer of an AI-enabled wearable device focused on remote respiratory health management, specifically targeting chronic obstructive pulmonary disease (COPD). The company's innovative chest patches utilize patented technology to diagnose COPD with 90% accuracy and identify exacerbation biomarkers at 83% accuracy, all while allowing patients to remain at home. The device continuously monitors various respiratory metrics, including pulmonary volumes, trapped air, respiratory and heart rates, breathing sounds, and temperature for up to two weeks. This real-time data collection empowers users to analyze their respiratory health and receive actionable insights to enhance their day-to-day well-being. Additionally, Samay is creating an AI-assisted management and diagnostic platform that supports both patients and doctors throughout the care continuum, from detecting exacerbations to determining effective therapies for more personalized treatment.

Active Therapy Systems is a company based in Nicholasville, Kentucky, founded in 2017. It specializes in developing an interactive exercise platform designed to provide in-home therapies for individuals living with Parkinson's disease. The platform aims to enhance the management of Parkinson's through personalized therapies and remote patient monitoring, allowing users to engage in activities that may help alleviate their symptoms. By focusing on the specific needs of those affected by Parkinson's, Active Therapy Systems seeks to improve their quality of life and promote greater independence in daily activities.

Plasmonic Diagnostics is a biotechnology company focused on developing innovative diagnostic systems for infectious diseases, sexually transmitted infections, and cancer. Utilizing advanced single molecule detection technology, the company aims to create non-invasive and highly sensitive testing devices that target specific biomarkers. Their offerings include 3D-printed components and a smartphone camera as a detector, allowing for efficient time-to-detection, intrinsic signal amplification, and a high signal-to-noise ratio. This approach not only enhances the accuracy of diagnostics but also aims to make testing more affordable and accessible for patients.

At SIPPA Solutions, we build technology to empower individuals with tools to securely exchange and consolidate health data with privacy assurance, and to transform their data to actionable plan for achieving self-management and personalized healthcare.

VitalFlo Inc. is a digital health company based in Raleigh, North Carolina, established in 2017. It specializes in manufacturing handheld spirometers for asthmatic patients, allowing them to monitor their lung health and medication use. In addition to the spirometers, VitalFlo develops software that connects patients with chronic respiratory conditions to their healthcare providers. The company's remote monitoring system tracks lung function and environmental factors that may trigger asthma attacks, providing actionable insights to clinical teams. This innovative approach aims to reduce emergency room visits by offering timely recommendations to patients, thereby redefining asthma management and enhancing overall care.

SageSurfer operates a mental healthcare platform designed to empower individuals in overcoming behavioral health challenges by fostering collaboration among their caregivers. The platform facilitates comprehensive, coordinated, and outcome-driven personalized care for mental health and addiction treatment. It enables consumers to actively participate in their care planning, ensuring they have a stronger voice in their treatment process. By centering the consumer in the recovery plan and providing access to their entire care team, SageSurfer aims to create a supportive healthcare environment where individuals are not alone in their journey towards recovery and can easily access help when needed.

Aluna, established in 2013 and headquartered in San Francisco, specializes in developing medical devices and digital health platforms for managing chronic respiratory conditions, primarily asthma. The company's core product is a portable spirometry device that connects with an interactive iPhone game, enabling users, especially children, to track and monitor their asthma symptoms, medication, and potential triggers in real-time. This data is shared with healthcare providers, facilitating personalized treatment plans and early intervention. Aluna's mission is to empower patients to understand and manage their lung health, improving overall asthma outcomes.

OESH Shoes provides groundbreaking research on the effects of common features of women’s shoes on the body—beyond the foot. Their OESHers wear multiple styles and colours of OESH as their brand of choice to maintain optimal fitness, comfort, and health with specific conditions.

Phase Scientific is a biotechnology company focused on developing diagnostic and data tools aimed at enhancing healthcare delivery for providers and patients. The firm specializes in creating point-of-care diagnostic kits that address significant unmet testing needs, including sexually transmitted diseases and malaria. Their innovative solutions utilize a paper microfluidic concentration platform to enable the replacement of traditional lab-based assays, thereby increasing accessibility to essential testing in previously underserved locations. In addition to infectious disease diagnostics, Phase Scientific offers a range of tools for cancer diagnostics and molecular testing, including liquid biopsies and various extraction and preparation techniques for DNA and RNA. Through these advancements, the company strives to improve patient outcomes and streamline healthcare management.

At SIPPA Solutions, we build technology to empower individuals with tools to securely exchange and consolidate health data with privacy assurance, and to transform their data to actionable plan for achieving self-management and personalized healthcare.

Aipiphany is a provider of innovative AI-driven solutions designed to enhance patient education and engagement within healthcare settings. By leveraging advanced algorithms and machine-learning techniques, Aipiphany's platform, Aipiphany Notes, transforms physicians' electronic health record (EHR) notes into accessible, interactive tools for both staff and patients. This approach fosters collaboration between patients and healthcare providers, promoting shared ownership of health outcomes. The platform personalizes medical content delivery based on patients' individual beliefs and perceptions, enabling them to better understand medical terminology and improve their overall care. By enhancing medication adherence and reducing readmission rates, Aipiphany aims to democratize medical knowledge and empower patients in their healthcare journeys.

Elidah, Inc. is a medical device company based in Monroe, Connecticut, that focuses on addressing urinary incontinence in women. Founded in 2015, the company has developed Elitone, a non-invasive device designed to stimulate and strengthen pelvic floor muscles. This device utilizes an external electrode placed in the perineal region to transmit a microcurrent, effectively toning the pelvic floor muscles and providing women with greater control over their bladders. By offering a practical solution for both stress and urge incontinence, Elidah aims to empower women to maintain an active lifestyle without the anxiety of leaks or frequent bathroom trips.

Bold Diagnostics is a medical device startup focused on developing an innovative diagnostic platform for blood pressure monitoring. The company has created a device that optimizes hypertension and pressure management by utilizing a novel parameter to derive noninvasive, cuffless blood pressure measurements. This pocket-sized device allows for ambulatory cardiovascular diagnostics, providing both patients and physicians with an accurate, comfortable, and convenient alternative for measuring and monitoring blood pressure. Through its technology, Bold Diagnostics aims to enhance the management of cardiovascular health.

Aluna, established in 2013 and headquartered in San Francisco, specializes in developing medical devices and digital health platforms for managing chronic respiratory conditions, primarily asthma. The company's core product is a portable spirometry device that connects with an interactive iPhone game, enabling users, especially children, to track and monitor their asthma symptoms, medication, and potential triggers in real-time. This data is shared with healthcare providers, facilitating personalized treatment plans and early intervention. Aluna's mission is to empower patients to understand and manage their lung health, improving overall asthma outcomes.

OESH Shoes provides groundbreaking research on the effects of common features of women’s shoes on the body—beyond the foot. Their OESHers wear multiple styles and colours of OESH as their brand of choice to maintain optimal fitness, comfort, and health with specific conditions.

Volumetrix focuses on creating innovative non-invasive monitoring technologies designed to improve individual well-being. The company develops sensors that capture venous waveforms, allowing for the assessment of various physiological conditions. This technology enables clinicians to accurately monitor patient health and detect congestion in diverse settings, including hospitals and homes. Volumetrix collaborates closely with patients and healthcare practitioners to ensure effective implementation and utilization of its monitoring solutions.

AbiliLife, Inc. is a Pennsylvania-based company focused on creating biomedical solutions for individuals suffering from neurodegenerative disorders, particularly Parkinson's disease. Incorporated in 2014, AbiliLife designs and manufactures innovative products aimed at enhancing the quality of life for patients. One of its key offerings is Calibrace, a specialized brace that assists patients in restoring equilibrium through a back tensioning system. This product is designed to improve posture, positioning, and balance, providing users with postural stability and relief from discomfort associated with neurodegenerative conditions.

WiseWear is an award-winning Internet of Things (IoT) company that designs and develops a range of connected devices and services aimed at enhancing health, safety, and security for families. By integrating proprietary biosensing and wireless communication technologies into everyday items, WiseWear makes technology seamlessly blend into daily life. The company's devices track human activities and can send notifications to emergency contacts in critical situations, as well as provide mobile alerts for important calls, texts, and reminders. This innovative approach allows consumers to effectively manage their health and wellness while enjoying stylish and functional products.

Phase Scientific is a biotechnology company focused on developing diagnostic and data tools aimed at enhancing healthcare delivery for providers and patients. The firm specializes in creating point-of-care diagnostic kits that address significant unmet testing needs, including sexually transmitted diseases and malaria. Their innovative solutions utilize a paper microfluidic concentration platform to enable the replacement of traditional lab-based assays, thereby increasing accessibility to essential testing in previously underserved locations. In addition to infectious disease diagnostics, Phase Scientific offers a range of tools for cancer diagnostics and molecular testing, including liquid biopsies and various extraction and preparation techniques for DNA and RNA. Through these advancements, the company strives to improve patient outcomes and streamline healthcare management.

Awarables Inc. develops innovative hardware and software solutions focused on sleep monitoring and enhancement. Founded in 2013 and based in Baltimore, Maryland, the company offers a multi-sensor wearable device that captures physiological data, such as heart rate, alongside environmental factors affecting sleep. Its mobile application tracks user sleep habits, daytime performance, and mood, providing personalized therapy to improve overall sleep health. Awarables' sleep analytic system combines data from microsensors with proprietary algorithms to deliver accurate assessments of sleep quality and quantity, aiding both clinicians and consumers in achieving better sleep outcomes.

Sanguina is a medical device and wellness tool company that specializes in point-of-care diagnostics, particularly for hemoglobin determination. The company is focused on launching its first product, AnemoCheck Mobile, which is a non-invasive smartphone application designed for tracking hemoglobin levels without the need for painful blood draws. This innovative approach emphasizes anemia screening through color-based testing, allowing users to conveniently monitor their hemoglobin levels.

Elidah, Inc. is a medical device company based in Monroe, Connecticut, that focuses on addressing urinary incontinence in women. Founded in 2015, the company has developed Elitone, a non-invasive device designed to stimulate and strengthen pelvic floor muscles. This device utilizes an external electrode placed in the perineal region to transmit a microcurrent, effectively toning the pelvic floor muscles and providing women with greater control over their bladders. By offering a practical solution for both stress and urge incontinence, Elidah aims to empower women to maintain an active lifestyle without the anxiety of leaks or frequent bathroom trips.

OESH Shoes provides groundbreaking research on the effects of common features of women’s shoes on the body—beyond the foot. Their OESHers wear multiple styles and colours of OESH as their brand of choice to maintain optimal fitness, comfort, and health with specific conditions.

Breezing is a company focused on developing innovative technology for health management and disease prevention through early detection. It has introduced a mobile metabolism tracker, the first of its kind, which measures resting energy expenditure and respiratory exchange ratio to assess metabolic rates. The device is user-friendly, requiring no nose clips and featuring automatic calibration, making it accessible for a wide range of users. By analyzing oxygen and carbon dioxide levels, the tracker enables fitness enthusiasts to create personalized diet and exercise plans, thereby enhancing their training and overall health. Breezing's contributions to the field have garnered attention from notable media outlets, reflecting its commitment to advancing health technology.

CREmedical, founded in 2011 and headquartered in Kingston, Rhode Island, specializes in the development of electroencephalography equipment aimed at enhancing the understanding of brain function and aiding in the diagnosis and treatment of mental illnesses and brain disorders. The company's innovative devices monitor brainwaves and are designed to facilitate the recording of electroencephalograms (EEGs) in home settings. This technology not only assists healthcare professionals in detecting life-threatening events but also has the potential to prevent seizures, thereby improving patient care and outcomes.

At SIPPA Solutions, we build technology to empower individuals with tools to securely exchange and consolidate health data with privacy assurance, and to transform their data to actionable plan for achieving self-management and personalized healthcare.

Awarables Inc. develops innovative hardware and software solutions focused on sleep monitoring and enhancement. Founded in 2013 and based in Baltimore, Maryland, the company offers a multi-sensor wearable device that captures physiological data, such as heart rate, alongside environmental factors affecting sleep. Its mobile application tracks user sleep habits, daytime performance, and mood, providing personalized therapy to improve overall sleep health. Awarables' sleep analytic system combines data from microsensors with proprietary algorithms to deliver accurate assessments of sleep quality and quantity, aiding both clinicians and consumers in achieving better sleep outcomes.

ChromaDex Corporation is a global nutraceutical company based in Los Angeles, California, focused on promoting healthy aging through innovative ingredient technologies. The company is best known for its flagship product, Nicotinamide riboside (NIAGEN), a patented form of vitamin B3 that enhances nicotinamide adenine dinucleotide (NAD+) levels, which naturally decline with age. In addition to NIAGEN, ChromaDex offers Immulina, a spirulina extract designed to improve immune function. The company operates through three main segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services, with the majority of its revenue generated from the Consumer Products segment. ChromaDex markets its products directly in the United States and Canada, while also utilizing international distributors, and employs in-house expertise in chemistry, regulatory affairs, and safety consulting to develop commercially viable ingredients across various industries, including dietary supplements, food, beverage, skin care, and pharmaceuticals.

Rubitection Inc. is a company based in Pittsburgh, Pennsylvania, specializing in early assessment and management of skin health, particularly focusing on the prevention of bedsores and diabetic foot ulcers. Founded in 2010, Rubitection has developed the Rubitect Assessment System, a handheld device designed for caregivers, doctors, and nurses to detect early signs of skin issues. This system provides features such as risk analytics, remote monitoring, and care plan management, allowing users to measure changes in tissue properties and assess overall skin health. Rubitection aims to establish itself as the global standard for skin health monitoring and care management, applicable not only in wound care but also in dermatology and cosmetic fields.

Quick-Med Technologies, Inc. is a life sciences company dedicated to developing proprietary technologies aimed at infection prevention and control in both medical and consumer healthcare markets. Founded in 1997 and headquartered in Gainesville, Florida, the company specializes in biomedical products and devices with antibacterial applications. Its core technologies include Novel Intrinsically Micro-Bonded Utility Substrate (NIMBUS), a series of advanced polymers with antimicrobial and hemostatic properties; Stay Fresh, a chemical formulation for textiles that provides durable antimicrobial protection; and MultiStat, which comprises patented methods and compounds for skin therapy. Quick-Med serves a diverse range of clients, including government agencies, healthcare providers, and companies in the apparel, textile, and personal care sectors.

CREmedical, founded in 2011 and headquartered in Kingston, Rhode Island, specializes in the development of electroencephalography equipment aimed at enhancing the understanding of brain function and aiding in the diagnosis and treatment of mental illnesses and brain disorders. The company's innovative devices monitor brainwaves and are designed to facilitate the recording of electroencephalograms (EEGs) in home settings. This technology not only assists healthcare professionals in detecting life-threatening events but also has the potential to prevent seizures, thereby improving patient care and outcomes.

Biorasis, established in December 2007, focuses on developing needle-implantable biosensors for real-time, continuous monitoring of various bio-analytes. Initially aimed at commercializing a miniaturized sensor platform from UCONN and OSCI for glucose monitoring, the company is expanding its technology to track other critical metabolites associated with disorders such as cardiovascular issues, cancer, liver and kidney abnormalities, stroke, and epilepsy. Biorasis's biosensors enable effective diabetes management and enhance metabolic monitoring for drug research and development, allowing healthcare professionals to minimize tissue damage during implantation procedures.

NanoCytomics is a healthcare technology company focused on enhancing cancer survival rates through innovative diagnostic solutions. The firm has developed a platform that offers accurate, low-cost, and non-invasive tests for use in primary care settings. By utilizing advanced optical imaging and sensing technologies, NanoCytomics enables healthcare providers to study the structures and functions of cells, facilitating improved patient outcomes. Their approach aims to provide creative cancer treatment options, making critical diagnostics more accessible and effective for patients and healthcare services alike.